Company Performance: Profitability, revenue growth, and debt levels directly influence investor confidence.

Industry Trends: Overall health and prospects of the pharmaceutical sector impact stock valuation.

Regulatory Changes: New drug approvals, policy shifts, and healthcare reforms affect future earnings.

Market Sentiment: General investor mood and economic outlook can drive buying or selling pressure.

Macroeconomic Factors: Interest rates, inflation, and GDP growth influence investment decisions.

Competitor Actions: Performance of rival companies and their strategic moves can affect market share.

Global Events: Geopolitical instability or global health crises may impact supply chains and demand.

Specific News: Announcements about drug trials, partnerships, or acquisitions drive stock fluctuations.

Dividend Policy: Decisions regarding dividend payouts can influence investor interest and stock price.

Technological Advancements: Disruptive technologies and innovative drug development can impact competitiveness.